Catalyst Wire Dossier Catalyst Wire Dossier

Vanucizumab

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vanucizumab, covering 2020-03-25 to 2020-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer [Phase 2]

See pricing